Beida Pharmaceuticals is going to the Hong Kong Stock Exchange to list, and two more anti-cancer
Time of Update: 2021-03-04
cancer, ensartinib, in the second decade. this is a new powerful, highly selective new generation of APK inhibitors, by effectively inhibiting the activity of APK, to inhibit tumor growth. 2020, Nsatinib was approved for listing in China
New anti-inflammatory drugs! AbbVie oral JAK1 inhibitor Rinvoq has been approved by the European Union to treat 2 new rheumatoids!
Time of Update: 2021-03-04
studies, Rinvoq reached the primary endpoint of the ACR20 response compared to a placebo. , 15 mg doses of Rinvoq and Adamo monoantigen showed non-poor effectiveness in treating the ACR20 response at week 12. patients treated with Rinvoq
Chinese scientists have discovered a new anti-aging target gene
Time of Update: 2021-03-04
scientists in China have revealed the principle of aging from the nervous system and genes, and discovered BAZ2B, a new anti-aging target gene, which provides a new theoretical basis for delaying brain aging. In the early hours of February
Beijing Zhisheng Weihua Chemical provides a variety of models of heavy anti-corrosion paint
Time of Update: 2021-03-04
-corrosion coatings that hold hydrofluoric acid, ZS-1041 anti-corrosion coatings that are resistant to high temperature flue gas and flue gas condensate corrosion, and ZS-1041 anti-corrosion coatings that are resistant to sea and sea moisture corrosion S-711
A screen to identify drug resistant variants to target-directed anti-cancer agents
Time of Update: 2021-03-04
Using imatinib and BCR/ABL as a paradigm for a drug-target pair, we recently reported a retroviral vector-based screening strategy to identify the spectrum of resistance-conferring mutations.
Enzyme-linked immunology analysis of free fatty acids (FFA) in rats
Time of Update: 2021-03-04
); "> Rats < FONT-WEIGHT: bold; FONT-SIZE: 14.0pt; COLOR: rgb (0,0,0); > free fatty acids (FFA). < :" FONT-WEIGHT: bold; FONT-SIZE: 14.0pt; "> enzyme-linked immunity < FONT-WEIGHT
Progress was made in the evaluation of silver ring snake toxin and clinical anti-silver ring snake serum
Time of Update: 2021-03-03
The Biotoxin and Human Diseases Unit of the Kunming Institute of Zoology of the Chinese Academy of Sciences studied silver ring snakes and obtained high-purity a-bungarotoxin, b-bungarotoxin and g-bungarotoxin by traditional separation and purification methods.
JCI Insight: "Treasure" Ginger! Not only can take on the "big responsibility" of anti-inflammatory
Time of Update: 2021-03-03
tested the effects of 6-turmericol on the activity of phosphate phosphatase (PDE) in neophilic granulocytes and found that 6-turmericol reduced PDE activity by 40%, while significantly increasing the concentration of cAMP in cells and the activity of PKA
China's first global anti-cancer drug, Bai Yueze, ® approved at home
Time of Update: 2021-03-03
with lymphoma in China." Bai Yueze has been successfully listed at home and abroad, is in recent years the rise of China's innovative pharmaceutical industry, representing China's pharmaceutical enterprises have full strength for local patients
JESINDA: Two-wheel drive mode to build a new anti-cancer drug pipeline
Time of Update: 2021-03-03
/> From starting a biopharmaceutical outsourcing service (CRO) to starting a new drug research and development company, dr. Zhang said in an interview that it was a challenging transition, with several successful examples of the industry's transition
Zhang Ya equal reveals the origin of experimental rats and the genetic mechanism of domestication
Time of Update: 2021-03-03
memory may be the key to the domestication of experimental rats. In addition, based on transcription group analysis and qPCR data, energy metabolism-related genes were significantly increased in brain tissue in experimental rats, which laid a good foundation for further revealing the genetic mechanism of domestication in experimental rats. (Source: Science Network Guo Shuang)
The FDA awarded Gilead CD47 a single anti-breakthrough drug
Time of Update: 2021-03-02
Gilead Sciences recently announced that the U.S. Food and Drug Administration (FDA) has granted magolimab breakthrough drug qualification (BTD), the first anti-CD47 monoclonal antibody to treat newly diagnosed bone marrow growth abnormality syndrome (MDS).
Gene-Array Analysis of Glioma Cells After Treatment With an Anti-PKC siRNA: A General Protocol
Time of Update: 2021-03-02
Post-transcriptional gene silencing is a powerful tool to reveal gene function.
